PharmaReports: Cardiovascular Disorders
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
Reports relating to all aspects of cardiovascular disease are included here with the exception of those relating to neurodegenerative components of stroke. Reports with a focus on atherosclerosis are also included here
Showing results 51 - 100 of 131
- ANEMIA - Therapy Area Pipeline Report
- HEMOPHILIA OR BLOOD COAGULATION DISORDERS - Therapy Area Pipeline Report
- THROMBOEMBOLISM - Therapy Area Pipeline Report
- Critical Limb Ischemia-US Epidemiology
- ANGINA - Therapy Area Pipeline Report
- ARRHYTHMIAS - Therapy Area Pipeline Report
- ATHEROSCLEROSIS and CORONARY ARTERY DISEASE - Therapy Area Pipeline Report
- CONGESTIVE HEART FAILURE - Therapy Area Pipeline Report
- EDEMA - Therapy Area Pipeline Report
- HYPERTENSION - Therapy Area Pipeline Report
- INTERMITTENT CLAUDICATION - Therapy Area Pipeline Report
- ISCHEMIA - Therapy Area Pipeline Report
- MYOCARDIAL INFARCTION - Therapy Area Pipeline Report
- PERIPHERAL VASCULAR DISEASE - Therapy Area Pipeline Report
- STROKE - Therapy Area Pipeline Report
- THROMBOSIS - Therapy Area Pipeline Report
- THROMBOEMBOLISM - Therapy Area Pipeline Report
- THROMBOSIS - Therapy Area Pipeline Report
- Innovations in Cardiovascular Disease Management: Latest surgical procedures, drugs and medical devices
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Anti-Obesity Treatments 2007-2012 - A blockbuster market
- The World Cardiovascular Drug Market: Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents
- Commercial Insight: Cardiovascular market overview - Raft of patent expires threaten blockbusters
- Commercial Insight: Antithrombotics - Market expands as disease management focuses on prevention
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Stakeholder Insight: Acute Stroke - TPA spurs infrastructure changes for the better
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Translational Medicine in Biopharmaceutical Research and Development
- The World Hypertension Market 2007-2023
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Ventricular Fibrillation and Atrial Fibrillation
- Diabetic Nephropathy - Prevalence and Therapeutic Potential
- 2003 Cardiovascular Market Update
- Thrombosis in Cancer - Expanding Focus for Anticoagulants
- Stakeholder Insight: Atrial Fibrillation - Future Advances in Stroke Prevention
- Commercial Insight: Antithrombotics - Sanofi-Aventis the Dominant Player
- Pipeline Insight: Antihypertensives - Together We Stand, Divided We Fail
- Stakeholder Insight: Metabolic Syndrome - Multiple definitions complicate treatment
- The Outlook for Cardiovascular Risk Factors: Epidemiology, market and pipeline analysis
- The Cardiovascular Market Outlook to 2008
- Commercial Opportunities from an Aging Population: Epidemiology, market and pipeline analysis across seven major indications
- New Anticoagulant Therapies: A Market Briefing
- Cardiovascular Disease: The 45+ Market in the United States for Drugs and Medical Devices
- Gene Expression Profiling Markets
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Pipeline perspectives: Peripheral artery disease Poor disease awareness hinders new agents
- How to Conduct Clinical Trials in China
- The Anti-Migraine Market 2007-2022
- Congestive Heart Failure: Major World Markets - Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets)
- Stakeholder Insight: Acute Coronary Syndromes Fresh look at ACS in Europe, what is the real picture
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development